Agreeing with these findings is the recent study by Nevado et al. (2022) on a cohort of n = 210 who reported that 22% of people with PMS had a renal disorder, that renal disorders were associated with larger deletion sizes, and only 1 case of renal disorder was observed in the group with SHANK3 variants [61]. This evidence concerns the gene SHANK3 and kidney disorder.